Background: Pre-emptive analgesia involves the introduction of an analgesic regimen before the onset of noxious stimuli, with the goal of preventing sensitization of the nervous system to subsequent stimuli that could amplify pain. The present study assessed the role of gabapentin as a pre-emptive analgesic in modified radical mastectomy. Materials & Methods: 80 female patients of ASA grade I and II of carcinoma breast posted for modified radical mastectomy under general anesthesia were divided into 2 groups. Each group comprised of 40 patients. Group I patients received tab. 600 mg Gabapentin orally before surgery and group II did not receive any drug before surgery. Parameters such as sedation score, VAS and side effects was recorded. Results: The mean age in group I was 46.4 years and in group II was 48.2 years. The mean weight in group I was 52.8 kgs and 53.1 kgs in group II. Duration of surgery was 1.9 hours in group I and 2.8 hours in group II. Duration of post- op analgesia was 5.1 hours in group I and 1.9 hours in group II. The difference was significant (P< 0.05). The mean VAS score in group I was 5.4 and in group II was 6.7. The mean sedation score in group I was 1.7 and in group II was 0.5. Common side effects was nausea/ vomiting seen in 7 in group I and 3 in group II, pruritis 1 in group I, urinary retention in 1 in group I and 2 in group II, headache 3 in group I and 2 in group II, constipation 1 in group I. The difference was significant (P< 0.05). Conclusion: Gabapentin prolongs postoperative analgesia as compare to control group. Preoperative gabapentin is effective as a pre-emptive analgesic in MRM, reducing postoperative pain and opioid consumption with minimal side effects.
Pre-emptive analgesia, an evolving clinical concept, involves the introduction of an analgesic regimen before the onset of noxious stimuli, with the goal of preventing sensitization of the nervous system to subsequent stimuli that could amplify pain.1 Surgery offers the most promising setting for pre-emptive analgesia because the timing of noxious stimuli is known. Surgical trauma induces nociceptive sensitization leading to amplification and prolongation of post-operative pain.2 Pre-emptive analgesia, an evolving clinical concept, involves the introduction of an analgesic regimen before the onset of noxious stimuli, with the goal of preventing sensitization of the nervous system to subsequent stimuli that could amplify pain. Surgery offers the most promising setting for pre-emptive analgesia because the timing of noxious stimuli is known. Surgical trauma induces nociceptive sensitization leading to amplification and prolongation of post-operative pain.3 Gabapentin is a structural analog of gamma amino butyric acid. Large placebo controlled, double-blind trials confirmed their effectiveness in relieving neuropathic post-herpetic pain and reflex sympathetic dystrophy.4 The most effective pre-emptive analgesic regimens are those, which are capable of limiting sensitization of the nervous system throughout the entire peri-operative period.5 The only way to prevent sensitization of the nociceptive system might be to block completely any pain signal, originating from the surgical wound from the time of incision until final wound healing.6 The present study assessed the role of gabapentin as a pre-emptive analgesic in modified radical mastectomy.
The present study comprised of 80 female patients of ASA grade I and II of carcinoma breast posted for modified radical mastectomy under general anesthesia. All were informed regarding the study and their written consent was obtained. Data such as name, age, etc. was recorded. Patients were divided into 2 groups. Each group comprised of 40 patients. Group I patients received tab. 600 mg Gabapentin orally before surgery and group II did not receive any drug before surgery. All the surgeries were done in routine general anaesthesia with endotracheal intubation. All patients were given analgesia in form of Inj. Fentanyl 100 mcg & Inj. Diclofenac Sodium 75 mg IV intra-operatively. Parameters such as sedation score and VAS was recorded. Results were subjected to statistical analysis. P value less than 0.05 was considered significant.
Table I Demographic data
|
Parameters |
Group I |
Group II |
P value |
|
Age (years) |
46.4 |
48.2 |
0.12 |
|
Weight (kgs) |
52.8 |
53.1 |
0.24 |
|
Duration of surgery (hours) |
1.9 |
2.8 |
0.05 |
|
Duration of post- op analgesia (hours) |
5.1 |
1.9 |
0.01 |
Table I, graph I shows that mean age in group I was 46.4 years and in group II was 48.2 years. The mean weight
in group I was 52.8 kgs and 53.1 kgs in group II. Duration of surgery was 1.9 hours in group I and 2.8 hours in
group II. Duration of post- op analgesia was 5.1 hours in group I and 1.9 hours in group II. The difference was
significant (P< 0.05).
Graph I Demographic data
Table II Comparison of parameters
|
Parameters |
Variables |
Group I |
Group II |
P value |
|
VAS |
5.4 |
6.7 |
0.08 |
|
|
Sedation score |
1.7 |
0.5 |
0.01 |
|
|
Side effects |
Nausea/ vomiting |
7 |
3 |
0.05 |
|
Pruritis |
1 |
0 |
||
|
Urinary retention |
1 |
2 |
||
|
Headache |
3 |
2 |
||
|
Constipation |
1 |
0 |
||
Table II, graph II shows that mean VAS score in group I was 5.4 and in group II was 6.7. The mean sedation
score in group I was 1.7 and in group II was 0.5. Common side effects was nausea/ vomiting seen in 7 in group I
and 3 in group II, pruritis 1 in group I, urinary retention in 1 in group I and 2 in group II, headache 3 in group I
and 2 in group II, constipation 1 in group I. The difference was significant (P< 0.05).
Graph II Comparison of parameters
Authors found that gabapentin prolongs postoperative analgesia as compare to control group. Preoperative gabapentin is effective as a pre-emptive analgesic in MRM, reducing postoperative pain and opioid consumption with minimal side effects.
14. Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.The Clinical journal of pain. 2010 Jun 1;26(5):381-5.